Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reveal Sciences was a biotechnology company that specialized in molecular diagnostics for the skin health and wellness industries. Launched through the Illumina Accelerator, the company developed a proprietary, non-invasive sampling technology to collect and analyze skin biomarkers, including proteins and nucleic acids. Their platform was designed to provide objective, data-driven insights into skin conditions such as aging and inflammation, enabling personalized skincare recommendations and tracking treatment efficacy. By bridging the gap between clinical genomics and consumer personal care, Reveal Sciences aimed to transform how consumers and practitioners assess skin health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reveal Sciences.